Drug intelligence / Profile preview

Lanzhang Granules

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Lanzhang Granules is a Traditional Chinese Medicine (TCM) formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically indicated for the treatment of non-alcoholic fatty liver disease (NAFLD) in patients presenting with the 'spleen deficiency and phlegm stasis' syndrome according to TCM diagnostic criteria. The formulation is designed to address the metabolic imbalances and hepatic fat accumulation associated with NAFLD. It is currently undergoing clinical evaluation in randomized, double-blind, placebo-controlled trials to determine its efficacy and safety in improving liver function and metabolic parameters.

Brand names
lanzhang granules
Other names
lanzhang granules
02

Targets

EHHADH (Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase)ACOX1 (Peroxisomal acyl-CoA oxidase 1)TNFA (Tumor necrosis factor alpha (soluble))PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Lanzhang Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lanzhang Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call